Cleveland, OHNCT06657183Now EnrollingIRB Ready

Febrile Neutropenia Clinical Trial in Cleveland, OH

Access cutting-edge febrile neutropenia treatment through this clinical trial at a research site in Cleveland. Study-provided care at no cost to qualified participants.

Sponsored by Case Comprehensive Cancer Center

Quick Self-Assessment

See if you qualify for this Cleveland location

Preparing your pre-screening questions…

Expert Care in Cleveland

Access febrile neutropenia specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related febrile neutropenia treatment provided free

Apply for This Cleveland Location

Check if you qualify for this febrile neutropenia clinical trial in Cleveland, OH

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Cleveland

    Convenient for OH residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Cleveland site if eligible
  4. 4Begin participation

About This Febrile Neutropenia Study in Cleveland

Undergoing cancer treatment comes with various risks and side effects. This clinical trial aims to reduce those risks and side effects through continuous monitoring of vital signs and blood levels. The goal is to see if potential side effects can be identified and treated sooner. During this study, participants will wear an Alio Smartpatch™. The Alio Smartpatch™ is a wireless remote monitoring system. This device will measure participants' vital signs and blood levels. Participants will also be asked to use continuous glucose monitors to measure their glucose levels. The data collected on each participant from these devices will be remotely monitored at all times by clinical staff at a company known as Quantify Remote Care. If a participant's results look like they are experiencing a side effect, the participant will be contacted immediately by Quantify Remote Care team. The Quantify Remote Care team will function as an extension of the participant's cancer clinical team and will relay any significant issues back to them. Quantify Health also provides dietary and mental health support as needed for all participants.

Sponsor: Case Comprehensive Cancer Center

Who Can Participate

Inclusion Criteria

Individuals must meet all of the following inclusion criteria in order to be eligible to participate in the study:
Subjects have a diagnosis of soft tissue sarcoma, NSCLC, HNSCC, breast, pancreatic cancer, or melanoma
For Cohort 1 (n=15), participants are eligible if starting on a new chemotherapy regimen with either: (i) high risk (\> 20%) of febrile neutropenia as per NCCN MGF guidelines; or (ii) intermediate risk for febrile neutropenia AND one or more risk factors for febrile neutropenia:
Age \> or equal to 65 years
Advanced disease
Previous Chemotherapy or Radiation therapy
Preexisting neutropenia or bone marrow involvement with tumor
Open wounds or surgery in last 4 weeks
Poor performance status or poor nutritional status
Poor renal function (cr clearance \<50)
Total Bilirubin \>1.5 upper limit of normal
Cardiovascular Disease
Multiple Co-morbidities
HIV infection
For Cohort 2 (n=15) participants are eligible if starting on immunotherapy alone, or concurrent chemo-immunotherapy.
Participants are capable of giving informed consent
Participants must be able to read and/or to speak English
Participants who are 18 years of age or older
Expected chemotherapy treatment duration of at least 12 weeks

Exclusion Criteria

An individual who meets any of the following criteria will be excluded from participation in this study:
Participants who cannot read or speak English
Participants without any cellphone access

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Cleveland?

Yes, this clinical trial (NCT06657183) has an active research site in Cleveland, OH that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Febrile Neutropenia Treatment Options in Cleveland, OH

If you're searching for febrile neutropenia treatment options in Cleveland, OH, this clinical trial (NCT06657183) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Cleveland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced febrile neutropenia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all febrile neutropenia clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Cleveland, OH

See all pulmonary embolism clinical trials recruiting in Cleveland — not just this study.

Browse Pulmonary Embolism Trials in Cleveland →

Ready to Join in Cleveland?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Cleveland, OH